End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
33.63 CNY | +0.99% | +12.60% | +10.20% |
Apr. 22 | CSPC Innovation Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 19 | China's drugmakers can't sell mRNA shots but haven't quit yet | RE |
Sales 2024 * | 3.09B 426M | Sales 2025 * | 4.05B 559M | Capitalization | 47.24B 6.52B |
---|---|---|---|---|---|
Net income 2024 * | 806M 111M | Net income 2025 * | 1.06B 146M | EV / Sales 2024 * | 14.8 x |
Net cash position 2024 * | 1.57B 216M | Net cash position 2025 * | 5B 690M | EV / Sales 2025 * | 10.4 x |
P/E ratio 2024 * |
56.6
x | P/E ratio 2025 * |
44.1
x | Employees | 1,887 |
Yield 2024 * |
0.95% | Yield 2025 * |
0.42% | Free-Float | 22.71% |
1 day | +0.99% | ||
1 week | +12.60% | ||
Current month | +9.07% | ||
1 month | +10.84% | ||
3 months | +23.53% | ||
6 months | +71.29% | ||
Current year | +10.20% |
Managers | Title | Age | Since |
---|---|---|---|
Feng Han
CEO | Chief Executive Officer | 50 | 15-12-31 |
Long Dai
DFI | Director of Finance/CFO | 32 | 23-04-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wei Dong Pan
CHM | Chairman | 55 | - |
Huai Yu Wang
BRD | Director/Board Member | 61 | 15-12-31 |
Ji Yong Zhang
CHM | Chairman | - | 15-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 33.63 | +0.99% | 9,847,105 |
24-04-25 | 33.3 | +3.44% | 13,140,460 |
24-04-24 | 32.19 | +5.26% | 15,204,143 |
24-04-23 | 30.58 | +2.29% | 16,912,355 |
24-04-22 | 29.9 | +0.11% | 7,297,285 |
End-of-day quote Shenzhen S.E., April 25, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+10.20% | 6.52B | |
+8.20% | 7.78B | |
+0.34% | 7.38B | |
-8.10% | 3.67B | |
-13.13% | 3.44B | |
-14.57% | 1.17B | |
+8.34% | 934M | |
-42.27% | 879M | |
-18.90% | 836M | |
+0.32% | 711M |
- Stock Market
- Equities
- 300765 Stock